Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 81yo Male
Vitals: BP 94/54 mmHg, BMI 28.1, Weight 78.1 kg, HR 68 bpm
Labs: Glucose 89.1 mg/dL, Glucose (serum) 98.7 mg/dL, HbA1c 6.4 %, Total Cholesterol 178.7 mg/dL, HDL Cholesterol 44.6 mg/dL, Triglycerides 155.4 mg/dL, Creatinine 2.6 mg/dL
Active conditions: Prediabetes, Essential Hypertension
Medications: Simvastatin 20 MG Oral Tablet, lovastatin 40 MG Oral Tablet, lisinopril 2.5 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.4% (prediabetes range 5.7-6.4%)
- BMI 28.1 (overweight)
- Age 81 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 0yo Male
Vitals: BP 120/78 mmHg, Weight 10.0 kg, HR 88 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 120/78 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 55yo Male
Vitals: BP 100/71 mmHg, BMI 27.7, Weight 91.0 kg, HR 82 bpm
Labs: Total Cholesterol 156.7 mg/dL, HDL Cholesterol 54.2 mg/dL, Triglycerides 118.6 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.7 (overweight)
- Age 55 years (≥45 increases risk)

**Hypertension: LOW**
- Age 55 years (≥55 increases risk)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 73yo Female
Vitals: BP 139/77 mmHg, BMI 29.1, Weight 73.0 kg, HR 86 bpm
Labs: Glucose (serum) 65.8 mg/dL, HbA1c 5.1 %, Total Cholesterol 166.7 mg/dL, HDL Cholesterol 54.3 mg/dL, Triglycerides 137.0 mg/dL
Medications: atorvastatin 20 MG Oral Tablet, lisinopril 40 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 29.1 (overweight)
- Age 73 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 139/77 mmHg (elevated)
- Age 73 years (≥55 increases risk)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 30yo Female
Vitals: BP 121/80 mmHg, BMI 30.4, Weight 85.6 kg, HR 87 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.4 (obese)

**Hypertension: MODERATE**
- BP 121/80 mmHg (elevated)
- BMI 30.4 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 59yo Female
Vitals: BP 125/88 mmHg, BMI 30.2, Weight 71.7 kg, HR 86 bpm
Labs: Glucose 97.8 mg/dL, HbA1c 6.0 %, Total Cholesterol 177.1 mg/dL, HDL Cholesterol 70.1 mg/dL, Triglycerides 107.3 mg/dL, Creatinine 3.4 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.0% (prediabetes range 5.7-6.4%)
- BMI 30.2 (obese)
- Age 59 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BP 125/88 mmHg (elevated)
- BMI 30.2 (obesity increases BP risk)
- Age 59 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 59yo Female
Vitals: BP 116/86 mmHg, BMI 28.1, Weight 65.9 kg, HR 78 bpm
Labs: Glucose 98.7 mg/dL, HbA1c 6.2 %, Total Cholesterol 206.1 mg/dL, HDL Cholesterol 64.0 mg/dL, Triglycerides 186.4 mg/dL, Creatinine 3.5 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.2% (prediabetes range 5.7-6.4%)
- BMI 28.1 (overweight)
- Age 59 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BP 116/86 mmHg (elevated)
- Age 59 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 77yo Male
Vitals: BP 118/79 mmHg, BMI 27.7, Weight 95.7 kg, HR 87 bpm
Labs: Glucose 91.4 mg/dL, HbA1c 6.3 %, Total Cholesterol 183.4 mg/dL, HDL Cholesterol 59.6 mg/dL, Triglycerides 112.8 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Prediabetes
Medications: atorvastatin 40 MG Oral Tablet, lisinopril 5 MG Oral Tablet, Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 27.7 (overweight)
- Age 77 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 77 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 48yo Female
Vitals: BP 131/73 mmHg, BMI 30.3, Weight 62.1 kg, HR 71 bpm
Labs: Total Cholesterol 191.7 mg/dL, HDL Cholesterol 31.4 mg/dL, Triglycerides 121.5 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.3 (obese)
- Age 48 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 131/73 mmHg (elevated)
- BMI 30.3 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 45yo Male
Vitals: BP 136/84 mmHg, BMI 23.4, Weight 78.8 kg, HR 76 bpm
Labs: Glucose 64.3 mg/dL, HbA1c 5.9 %, Total Cholesterol 175.7 mg/dL, HDL Cholesterol 52.5 mg/dL, Triglycerides 148.2 mg/dL, Creatinine 1.1 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.9% (prediabetes range 5.7-6.4%)
- Age 45 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BP 136/84 mmHg (elevated)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 27yo Male
Vitals: BP 123/75 mmHg, BMI 21.9, Weight 75.8 kg, HR 75 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 123/75 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 14yo Male
Vitals: BP 123/79 mmHg, BMI 34.9, Weight 103.4 kg, HR 91 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 34.9 (obese)

**Hypertension: MODERATE**
- BP 123/79 mmHg (slightly elevated)
- BMI 34.9 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 59yo Female
Vitals: BP 107/70 mmHg, BMI 30.5, Weight 88.8 kg, HR 76 bpm
Labs: Glucose 83.0 mg/dL, HbA1c 6.2 %, Total Cholesterol 204.7 mg/dL, HDL Cholesterol 51.9 mg/dL, Triglycerides 128.4 mg/dL, Creatinine 3.0 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.2% (prediabetes range 5.7-6.4%)
- BMI 30.5 (obese)
- Age 59 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BMI 30.5 (obesity increases BP risk)
- Age 59 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 81yo Male
Vitals: BP 111/82 mmHg, BMI 33.5, Weight 93.7 kg, HR 83 bpm
Labs: Glucose 76.8 mg/dL, Glucose (serum) 81.1 mg/dL, HbA1c 5.5 %, Total Cholesterol 152.5 mg/dL, HDL Cholesterol 60.9 mg/dL, Triglycerides 148.9 mg/dL, Creatinine 3.4 mg/dL
Active conditions: Essential Hypertension
Medications: Simvastatin 20 MG Oral Tablet, lisinopril 10 MG Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 33.5 (obese)
- Age 81 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 67yo Male
Vitals: BP 111/69 mmHg, BMI 29.8, Weight 83.2 kg, HR 67 bpm
Labs: Glucose 84.5 mg/dL, HbA1c 6.3 %, Total Cholesterol 204.6 mg/dL, HDL Cholesterol 79.0 mg/dL, Triglycerides 165.5 mg/dL, Creatinine 3.0 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 29.8 (overweight)
- Age 67 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 67 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 79yo Male
Vitals: BP 71/45 mmHg, BMI 30.6, Weight 99.2 kg, HR 80 bpm
Labs: Glucose 75.0 mg/dL, HbA1c 6.0 %, Total Cholesterol 179.0 mg/dL, HDL Cholesterol 58.5 mg/dL, Triglycerides 108.4 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Prediabetes
Medications: simvastatin 20 MG Oral Tablet, losartan potassium 50 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.0% (prediabetes range 5.7-6.4%)
- BMI 30.6 (obese)
- Age 79 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BMI 30.6 (obesity increases BP risk)
- Age 79 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 67yo Male
Vitals: BP 116/66 mmHg, BMI 30.0, Weight 91.0 kg, HR 81 bpm
Labs: Glucose 120.1 mg/dL, Glucose (serum) 74.2 mg/dL, HbA1c 7.5 %, Total Cholesterol 215.2 mg/dL, HDL Cholesterol 57.7 mg/dL, Triglycerides 184.4 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Prediabetes, Essential Hypertension, Type 2 Diabetes
Medications: Simvastatin 20 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 6yo Male
Vitals: BP 110/67 mmHg, BMI 13.7, Weight 20.2 kg, HR 61 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 46yo Male
Vitals: BP 130/83 mmHg, BMI 37.3, Weight 105.2 kg, HR 94 bpm
Labs: Glucose 76.2 mg/dL, HbA1c 5.8 %, Total Cholesterol 164.2 mg/dL, HDL Cholesterol 55.1 mg/dL, Triglycerides 118.3 mg/dL, Creatinine 1.4 mg/dL
Active conditions: Prediabetes, Essential Hypertension
Medications: Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.8% (prediabetes range 5.7-6.4%)
- BMI 37.3 (obese)
- Age 46 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 5yo Female
Vitals: BP 111/82 mmHg, BMI 16.2, Weight 19.7 kg, HR 94 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 111/82 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 52yo Male
Vitals: BP 125/69 mmHg, BMI 27.6, Weight 79.0 kg, HR 62 bpm
Labs: Total Cholesterol 176.7 mg/dL, HDL Cholesterol 31.9 mg/dL, Triglycerides 100.3 mg/dL
Active conditions: Essential Hypertension
Medications: Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.6 (overweight)
- Age 52 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 48yo Female
Vitals: BP 124/69 mmHg, BMI 31.2, Weight 97.3 kg, HR 69 bpm
Labs: Total Cholesterol 278.8 mg/dL, HDL Cholesterol 53.4 mg/dL, Triglycerides 134.5 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 31.2 (obese)
- Age 48 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 124/69 mmHg (slightly elevated)
- BMI 31.2 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 40yo Male
Vitals: BP 110/75 mmHg, BMI 30.1, Weight 106.8 kg, HR 69 bpm
Labs: Total Cholesterol 192.9 mg/dL, HDL Cholesterol 68.8 mg/dL, Triglycerides 109.8 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.1 (obese)

**Hypertension: MODERATE**
- BMI 30.1 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 12yo Male
Vitals: BP 134/74 mmHg, BMI 26.1, Weight 58.0 kg, HR 61 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 26.1 (overweight)

**Hypertension: MODERATE**
- BP 134/74 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 34yo Male
Vitals: BP 131/96 mmHg, BMI 28.5, Weight 96.0 kg, HR 76 bpm
Labs: Total Cholesterol 185.0 mg/dL, HDL Cholesterol 49.1 mg/dL, Triglycerides 104.0 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 28.5 (overweight)

**Hypertension: HIGH**
- BP 131/96 mmHg (Stage 1+ hypertension)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 104yo Male
Vitals: BP 137/95 mmHg, BMI 31.9, Weight 119.3 kg, HR 70 bpm
Labs: Glucose 73.0 mg/dL, Glucose (serum) 90.8 mg/dL, Total Cholesterol 165.5 mg/dL, HDL Cholesterol 52.3 mg/dL, Triglycerides 146.7 mg/dL, Creatinine 0.7 mg/dL
Active conditions: Essential Hypertension, Diabetic Kidney Disease
Medications: lovastatin 20 MG Oral Tablet, lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 31.9 (obese)
- Age 104 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 50yo Female
Vitals: BP 96/82 mmHg, BMI 30.1, Weight 87.2 kg, HR 96 bpm
Labs: Total Cholesterol 259.0 mg/dL, HDL Cholesterol 56.4 mg/dL, Triglycerides 130.1 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.1 (obese)
- Age 50 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 96/82 mmHg (elevated)
- BMI 30.1 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 24yo Male
Vitals: BP 101/79 mmHg, BMI 30.6, Weight 90.5 kg, HR 78 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.6 (obese)

**Hypertension: MODERATE**
- BMI 30.6 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 29yo Female
Vitals: BP 127/88 mmHg, BMI 28.3, Weight 81.7 kg, HR 62 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 28.3 (overweight)

**Hypertension: MODERATE**
- BP 127/88 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 23yo Male
Vitals: BP 119/84 mmHg, BMI 25.5, Weight 82.2 kg, HR 92 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 25.5 (overweight)

**Hypertension: MODERATE**
- BP 119/84 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 84yo Female
Vitals: BP 103/69 mmHg, BMI 28.2, Weight 74.8 kg, HR 70 bpm
Labs: Glucose 89.6 mg/dL, HbA1c 5.9 %, Total Cholesterol 121.2 mg/dL, HDL Cholesterol 33.4 mg/dL, Triglycerides 104.0 mg/dL, Creatinine 0.5 mg/dL
Active conditions: Prediabetes
Medications: simvastatin 40 MG Oral Tablet, Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.9% (prediabetes range 5.7-6.4%)
- BMI 28.2 (overweight)
- Age 84 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 84 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 49yo Male
Vitals: BP 176/81 mmHg, BMI 27.5, Weight 94.6 kg, HR 84 bpm
Labs: Glucose (serum) 91.0 mg/dL, Total Cholesterol 158.4 mg/dL, HDL Cholesterol 56.4 mg/dL, Triglycerides 112.3 mg/dL
Active conditions: Essential Hypertension, Diabetic Kidney Disease
Medications: lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.5 (overweight)
- Age 49 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 13yo Male
Vitals: BP 104/84 mmHg, BMI 23.6, Weight 51.1 kg, HR 99 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 104/84 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 59yo Female
Vitals: BP 94/63 mmHg, BMI 29.4, Weight 73.5 kg, HR 94 bpm
Labs: Glucose 87.2 mg/dL, HbA1c 6.1 %, Total Cholesterol 197.8 mg/dL, HDL Cholesterol 46.5 mg/dL, Triglycerides 115.2 mg/dL, Creatinine 3.0 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.1% (prediabetes range 5.7-6.4%)
- BMI 29.4 (overweight)
- Age 59 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 59 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 29yo Female
Vitals: BP 120/80 mmHg, BMI 27.9, Weight 74.9 kg, HR 100 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.9 (overweight)

**Hypertension: MODERATE**
- BP 120/80 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 78yo Male
Vitals: BP 119/87 mmHg, BMI 30.2, Weight 87.0 kg, HR 85 bpm
Labs: Glucose 78.2 mg/dL, HbA1c 6.1 %, Total Cholesterol 176.0 mg/dL, HDL Cholesterol 57.0 mg/dL, Triglycerides 108.0 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Essential Hypertension, Prediabetes
Medications: Simvastatin 20 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.1% (prediabetes range 5.7-6.4%)
- BMI 30.2 (obese)
- Age 78 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 65yo Male
Vitals: BP 133/71 mmHg, BMI 27.3, Weight 84.1 kg, HR 85 bpm
Labs: Glucose 104.6 mg/dL, Glucose (serum) 106.7 mg/dL, HbA1c 3.8 %, Total Cholesterol 218.8 mg/dL, HDL Cholesterol 40.5 mg/dL, Triglycerides 155.4 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Type 2 Diabetes, Diabetic Kidney Disease
Medications: Simvastatin 20 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin]

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: MODERATE**
- BP 133/71 mmHg (elevated)
- Age 65 years (≥55 increases risk)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 62yo Female
Vitals: BP 122/71 mmHg, BMI 31.6, Weight 92.6 kg, HR 80 bpm
Labs: Glucose 70.1 mg/dL, HbA1c 6.4 %, Total Cholesterol 268.0 mg/dL, HDL Cholesterol 55.9 mg/dL, Triglycerides 133.0 mg/dL, Creatinine 1.4 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.4% (prediabetes range 5.7-6.4%)
- BMI 31.6 (obese)
- Age 62 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BP 122/71 mmHg (slightly elevated)
- BMI 31.6 (obesity increases BP risk)
- Age 62 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 50yo Male
Vitals: BP 128/80 mmHg, BMI 28.2, Weight 85.9 kg, HR 86 bpm
Labs: Glucose 82.3 mg/dL, HbA1c 6.3 %, Total Cholesterol 161.7 mg/dL, HDL Cholesterol 36.7 mg/dL, Triglycerides 125.8 mg/dL, Creatinine 3.4 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 28.2 (overweight)
- Age 50 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BP 128/80 mmHg (elevated)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 51yo Male
Vitals: BP 113/83 mmHg, BMI 29.1, Weight 98.0 kg, HR 73 bpm
Labs: Glucose 79.8 mg/dL, HbA1c 6.1 %, Total Cholesterol 156.6 mg/dL, HDL Cholesterol 53.4 mg/dL, Triglycerides 127.7 mg/dL, Creatinine 1.4 mg/dL
Active conditions: Prediabetes, Essential Hypertension
Medications: Simvastatin 20 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.1% (prediabetes range 5.7-6.4%)
- BMI 29.1 (overweight)
- Age 51 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 13yo Female
Vitals: BP 128/76 mmHg, BMI 20.7, Weight 48.4 kg, HR 98 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 128/76 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 87yo Male
Vitals: BP 119/75 mmHg, BMI 30.3, Weight 90.9 kg, HR 77 bpm
Labs: Glucose 99.7 mg/dL, HbA1c 6.1 %, Total Cholesterol 156.6 mg/dL, HDL Cholesterol 65.9 mg/dL, Triglycerides 184.5 mg/dL, Creatinine 3.5 mg/dL
Active conditions: Prediabetes, Type 2 Diabetes, Diabetic Neuropathy, Essential Hypertension
Medications: Simvastatin 20 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet, 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 7yo Female
Vitals: BP 133/80 mmHg, BMI 18.0, Weight 27.6 kg, HR 99 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 133/80 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 3yo Female
Vitals: BP 151/82 mmHg, BMI 15.2, Weight 14.0 kg, HR 98 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: HIGH**
- BP 151/82 mmHg (Stage 1+ hypertension)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 96yo Male
Vitals: BP 135/69 mmHg, BMI 28.0, Weight 78.9 kg, HR 82 bpm
Labs: Glucose 113.8 mg/dL, Glucose (serum) 113.8 mg/dL, HbA1c 4.0 %, Total Cholesterol 216.5 mg/dL, HDL Cholesterol 41.7 mg/dL, Triglycerides 154.1 mg/dL, Creatinine 2.0 mg/dL
Active conditions: Prediabetes, Type 2 Diabetes, Diabetic Kidney Disease
Medications: Simvastatin 10 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin]

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: MODERATE**
- BP 135/69 mmHg (elevated)
- Age 96 years (≥55 increases risk)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 77yo Male
Vitals: BP 116/68 mmHg, BMI 27.9, Weight 84.1 kg, HR 91 bpm
Labs: Glucose 99.6 mg/dL, HbA1c 6.2 %, Total Cholesterol 125.2 mg/dL, HDL Cholesterol 48.3 mg/dL, Triglycerides 110.7 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.2% (prediabetes range 5.7-6.4%)
- BMI 27.9 (overweight)
- Age 77 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 77 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 38yo Female
Vitals: BP 142/93 mmHg, BMI 27.9, Weight 73.5 kg, HR 90 bpm
Labs: Glucose 83.8 mg/dL, HbA1c 6.1 %, Total Cholesterol 150.3 mg/dL, HDL Cholesterol 51.0 mg/dL, Triglycerides 110.8 mg/dL, Creatinine 1.1 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.1% (prediabetes range 5.7-6.4%)
- BMI 27.9 (overweight)
- History of prediabetes

**Hypertension: HIGH**
- BP 142/93 mmHg (Stage 1+ hypertension)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Confirm elevated BP on 2 separate occasions
4. Consider initiating antihypertensive therapy
5. Order baseline labs: renal function, electrolytes, lipid panel
6. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 70yo Female
Vitals: BP 130/93 mmHg, BMI 28.0, Weight 70.3 kg, HR 95 bpm
Labs: Glucose 93.7 mg/dL, Glucose (serum) 87.1 mg/dL, HbA1c 2.5 %, Total Cholesterol 97.6 mg/dL, HDL Cholesterol 55.8 mg/dL, Triglycerides 129.2 mg/dL, Creatinine 2.5 mg/dL
Active conditions: Type 2 Diabetes, Essential Hypertension, Diabetic Neuropathy, Diabetic Kidney Disease, Diabetic Retinopathy
Medications: Simvastatin 20 MG Oral Tablet, Simvastatin 10 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 8yo Male
Vitals: BP 130/91 mmHg, BMI 21.7, Weight 32.1 kg, HR 90 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: HIGH**
- BP 130/91 mmHg (Stage 1+ hypertension)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 76yo Male
Vitals: BP 117/85 mmHg, BMI 30.4, Weight 84.0 kg, HR 90 bpm
Labs: Glucose 88.4 mg/dL, Glucose (serum) 96.0 mg/dL, HbA1c 3.2 %, Total Cholesterol 276.7 mg/dL, HDL Cholesterol 57.1 mg/dL, Triglycerides 138.0 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Essential Hypertension, Prediabetes, Diabetic Kidney Disease
Medications: insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.4 (obese)
- Age 76 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 27yo Female
Vitals: BP 129/74 mmHg, BMI 22.4, Weight 50.4 kg, HR 99 bpm
Labs: Glucose 89.5 mg/dL, HbA1c 5.9 %, Creatinine 0.7 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.9% (prediabetes range 5.7-6.4%)
- History of prediabetes

**Hypertension: LOW**
- BP 129/74 mmHg (slightly elevated)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 29yo Female
Vitals: BP 110/71 mmHg, BMI 27.5, Weight 69.1 kg, HR 90 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.5 (overweight)

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 66yo Female
Vitals: BP 119/94 mmHg, BMI 30.2, Weight 69.7 kg, HR 76 bpm
Labs: Total Cholesterol 188.3 mg/dL, HDL Cholesterol 56.8 mg/dL, Triglycerides 115.6 mg/dL
Active conditions: Essential Hypertension
Medications: lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.2 (obese)
- Age 66 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 35yo Female
Vitals: BP 128/88 mmHg, BMI 26.5, Weight 67.3 kg, HR 70 bpm
Labs: Total Cholesterol 164.2 mg/dL, HDL Cholesterol 52.2 mg/dL, Triglycerides 115.5 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 26.5 (overweight)

**Hypertension: MODERATE**
- BP 128/88 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 36yo Male
Vitals: BP 120/69 mmHg, BMI 30.0, Weight 92.8 kg, HR 77 bpm
Labs: Total Cholesterol 194.2 mg/dL, HDL Cholesterol 53.7 mg/dL, Triglycerides 109.9 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.0 (obese)

**Hypertension: MODERATE**
- BP 120/69 mmHg (slightly elevated)
- BMI 30.0 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 58yo Male
Vitals: BP 131/68 mmHg, BMI 30.3, Weight 100.8 kg, HR 83 bpm
Labs: Total Cholesterol 183.3 mg/dL, HDL Cholesterol 28.1 mg/dL, Triglycerides 120.3 mg/dL
Medications: Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.3 (obese)
- Age 58 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 131/68 mmHg (elevated)
- BMI 30.3 (obesity increases BP risk)
- Age 58 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 70yo Female
Vitals: BP 117/68 mmHg, BMI 31.4, Weight 88.4 kg, HR 62 bpm
Labs: Glucose 86.1 mg/dL, Glucose (serum) 86.1 mg/dL, HbA1c 3.4 %, Total Cholesterol 216.3 mg/dL, HDL Cholesterol 56.0 mg/dL, Triglycerides 135.7 mg/dL, Creatinine 2.2 mg/dL
Active conditions: Prediabetes, Type 2 Diabetes, Essential Hypertension, Diabetic Kidney Disease
Medications: Simvastatin 20 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], Hydrochlorothiazide 25 MG Oral Tablet, 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 0yo Male
Vitals: BP 136/84 mmHg, Weight 5.1 kg, HR 62 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 136/84 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 1yo Male
Vitals: BP 126/67 mmHg, Weight 11.2 kg, HR 88 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 126/67 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 51yo Male
Vitals: BP 101/78 mmHg, BMI 27.8, Weight 81.1 kg, HR 65 bpm
Labs: Glucose 124.2 mg/dL, Glucose (serum) 110.2 mg/dL, HbA1c 4.0 %, Total Cholesterol 210.7 mg/dL, HDL Cholesterol 40.1 mg/dL, Triglycerides 189.4 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Diabetic Kidney Disease, Type 2 Diabetes, Essential Hypertension
Medications: insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 67yo Female
Vitals: BP 108/74 mmHg, BMI 27.9, Weight 82.0 kg, HR 72 bpm
Labs: Glucose 88.6 mg/dL, HbA1c 6.0 %, Total Cholesterol 247.9 mg/dL, HDL Cholesterol 62.0 mg/dL, Triglycerides 129.2 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Prediabetes, Essential Hypertension
Medications: amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.0% (prediabetes range 5.7-6.4%)
- BMI 27.9 (overweight)
- Age 67 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 55yo Female
Vitals: BP 95/72 mmHg, BMI 27.9, Weight 70.3 kg, HR 70 bpm
Labs: Glucose 67.0 mg/dL, HbA1c 5.8 %, Total Cholesterol 186.0 mg/dL, HDL Cholesterol 54.4 mg/dL, Triglycerides 124.2 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.8% (prediabetes range 5.7-6.4%)
- BMI 27.9 (overweight)
- Age 55 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 55 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 20yo Male
Vitals: BP 101/80 mmHg, BMI 35.0, Weight 102.6 kg, HR 68 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 35.0 (obese)

**Hypertension: MODERATE**
- BP 101/80 mmHg (elevated)
- BMI 35.0 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 59yo Female
Vitals: BP 126/89 mmHg, BMI 27.9, Weight 69.6 kg, HR 98 bpm
Labs: Total Cholesterol 179.5 mg/dL, HDL Cholesterol 55.3 mg/dL, Triglycerides 111.8 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.9 (overweight)
- Age 59 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 126/89 mmHg (elevated)
- Age 59 years (≥55 increases risk)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 64yo Male
Vitals: BP 103/76 mmHg, BMI 28.8, Weight 93.1 kg, HR 71 bpm
Labs: Glucose 82.0 mg/dL, HbA1c 5.9 %, Total Cholesterol 137.8 mg/dL, HDL Cholesterol 54.2 mg/dL, Triglycerides 125.3 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.9% (prediabetes range 5.7-6.4%)
- BMI 28.8 (overweight)
- Age 64 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 64 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 74yo Male
Vitals: BP 135/85 mmHg, BMI 27.3, Weight 82.6 kg, HR 88 bpm
Labs: Glucose 92.2 mg/dL, Total Cholesterol 169.8 mg/dL, HDL Cholesterol 52.1 mg/dL, Triglycerides 102.8 mg/dL, Creatinine 3.3 mg/dL
Active conditions: Essential Hypertension
Medications: Simvastatin 20 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.3 (overweight)
- Age 74 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 11yo Female
Vitals: BP 116/78 mmHg, BMI 18.2, Weight 32.5 kg, HR 94 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 30yo Male
Vitals: BP 108/87 mmHg, BMI 26.4, Weight 83.7 kg, HR 84 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 26.4 (overweight)

**Hypertension: MODERATE**
- BP 108/87 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 68yo Male
Vitals: BP 135/93 mmHg, BMI 28.9, Weight 95.0 kg, HR 64 bpm
Labs: Glucose 70.9 mg/dL, Glucose (serum) 70.9 mg/dL, HbA1c 2.8 %, Total Cholesterol 239.9 mg/dL, HDL Cholesterol 49.1 mg/dL, Triglycerides 101.1 mg/dL, Creatinine 2.2 mg/dL
Active conditions: Essential Hypertension, Prediabetes, Diabetic Kidney Disease
Medications: simvastatin 20 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 28.9 (overweight)
- Age 68 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 13yo Male
Vitals: BP 135/77 mmHg, BMI 17.8, Weight 36.5 kg, HR 80 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 135/77 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 61yo Female
Vitals: BP 110/75 mmHg, BMI 30.2, Weight 93.0 kg, HR 88 bpm
Labs: Glucose 88.5 mg/dL, Glucose (serum) 91.6 mg/dL, HbA1c 4.6 %, Total Cholesterol 171.9 mg/dL, HDL Cholesterol 52.6 mg/dL, Triglycerides 126.3 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Prediabetes, Essential Hypertension, Diabetic Kidney Disease
Medications: Simvastatin 20 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], Hydrochlorothiazide 25 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.2 (obese)
- Age 61 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 13yo Male
Vitals: BP 126/79 mmHg, BMI 16.6, Weight 38.1 kg, HR 69 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 126/79 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 82yo Female
Vitals: BP 123/80 mmHg, BMI 29.9, Weight 79.2 kg, HR 71 bpm
Labs: Glucose 97.9 mg/dL, Total Cholesterol 194.3 mg/dL, HDL Cholesterol 57.1 mg/dL, Triglycerides 192.3 mg/dL, Creatinine 2.7 mg/dL
Medications: Simvastatin 20 MG Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 29.9 (overweight)
- Age 82 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 123/80 mmHg (elevated)
- Age 82 years (≥55 increases risk)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 72yo Male
Vitals: BP 124/70 mmHg, BMI 27.9, Weight 91.8 kg, HR 94 bpm
Labs: Glucose (serum) 71.9 mg/dL, HbA1c 5.3 %, Total Cholesterol 137.8 mg/dL, HDL Cholesterol 51.8 mg/dL, Triglycerides 129.9 mg/dL
Medications: Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.9 (overweight)
- Age 72 years (≥45 increases risk)

**Hypertension: LOW**
- BP 124/70 mmHg (slightly elevated)
- Age 72 years (≥55 increases risk)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 70yo Female
Vitals: BP 100/74 mmHg, BMI 27.7, Weight 69.7 kg, HR 93 bpm
Labs: Glucose 75.0 mg/dL, HbA1c 5.9 %, Total Cholesterol 183.3 mg/dL, HDL Cholesterol 53.5 mg/dL, Triglycerides 140.0 mg/dL, Creatinine 0.6 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.9% (prediabetes range 5.7-6.4%)
- BMI 27.7 (overweight)
- Age 70 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 70 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 40yo Male
Vitals: BP 121/72 mmHg, BMI 27.4, Weight 83.2 kg, HR 95 bpm
Labs: Glucose 66.7 mg/dL, HbA1c 6.1 %, Total Cholesterol 204.2 mg/dL, HDL Cholesterol 57.8 mg/dL, Triglycerides 119.8 mg/dL, Creatinine 1.5 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.1% (prediabetes range 5.7-6.4%)
- BMI 27.4 (overweight)
- History of prediabetes

**Hypertension: LOW**
- BP 121/72 mmHg (slightly elevated)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 41yo Male
Vitals: BP 107/75 mmHg, BMI 30.4, Weight 82.0 kg, HR 83 bpm
Labs: Glucose 83.8 mg/dL, HbA1c 5.9 %, Total Cholesterol 167.9 mg/dL, HDL Cholesterol 69.9 mg/dL, Triglycerides 101.6 mg/dL, Creatinine 1.3 mg/dL
Active conditions: Prediabetes, Essential Hypertension
Medications: lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.9% (prediabetes range 5.7-6.4%)
- BMI 30.4 (obese)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 60yo Female
Vitals: BP 127/92 mmHg, BMI 27.3, Weight 77.2 kg, HR 64 bpm
Labs: Total Cholesterol 291.1 mg/dL, HDL Cholesterol 51.9 mg/dL, Triglycerides 106.1 mg/dL
Active conditions: Essential Hypertension, Diabetic Kidney Disease
Medications: Hydrochlorothiazide 25 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.3 (overweight)
- Age 60 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 68yo Female
Vitals: BP 99/67 mmHg, BMI 27.6, Weight 76.4 kg, HR 72 bpm
Labs: Glucose 91.1 mg/dL, HbA1c 6.0 %, Total Cholesterol 163.7 mg/dL, HDL Cholesterol 55.1 mg/dL, Triglycerides 124.1 mg/dL, Creatinine 0.7 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.0% (prediabetes range 5.7-6.4%)
- BMI 27.6 (overweight)
- Age 68 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 68 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 43yo Female
Vitals: BP 145/83 mmHg, BMI 27.3, Weight 68.9 kg, HR 76 bpm
Labs: Total Cholesterol 96.8 mg/dL, HDL Cholesterol 57.2 mg/dL, Triglycerides 135.8 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.3 (overweight)

**Hypertension: HIGH**
- BP 145/83 mmHg (Stage 1+ hypertension)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 20yo Female
Vitals: BP 113/75 mmHg, BMI 20.5, Weight 60.6 kg, HR 90 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 44yo Male
Vitals: BP 99/73 mmHg, BMI 30.6, Weight 87.8 kg, HR 99 bpm
Labs: Total Cholesterol 120.3 mg/dL, HDL Cholesterol 50.8 mg/dL, Triglycerides 107.3 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.6 (obese)

**Hypertension: MODERATE**
- BMI 30.6 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 13yo Female
Vitals: BP 118/76 mmHg, BMI 19.8, Weight 47.1 kg, HR 76 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 36yo Male
Vitals: BP 128/88 mmHg, BMI 28.1, Weight 88.1 kg, HR 74 bpm
Labs: Total Cholesterol 181.4 mg/dL, HDL Cholesterol 54.0 mg/dL, Triglycerides 141.4 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 28.1 (overweight)

**Hypertension: MODERATE**
- BP 128/88 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 38yo Male
Vitals: BP 120/84 mmHg, BMI 29.4, Weight 90.5 kg, HR 78 bpm
Labs: Glucose 86.7 mg/dL, HbA1c 6.3 %, Total Cholesterol 212.1 mg/dL, HDL Cholesterol 29.8 mg/dL, Triglycerides 110.3 mg/dL, Creatinine 1.3 mg/dL
Active conditions: Prediabetes, Essential Hypertension
Medications: Hydrochlorothiazide 25 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 29.4 (overweight)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 61yo Female
Vitals: BP 117/98 mmHg, BMI 30.1, Weight 94.0 kg, HR 92 bpm
Labs: Total Cholesterol 152.2 mg/dL, HDL Cholesterol 29.2 mg/dL, Triglycerides 126.5 mg/dL
Active conditions: Essential Hypertension
Medications: amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.1 (obese)
- Age 61 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 8yo Male
Vitals: BP 99/69 mmHg, BMI 17.3, Weight 29.0 kg, HR 73 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 61yo Female
Vitals: BP 116/78 mmHg, BMI 30.3, Weight 96.3 kg, HR 82 bpm
Labs: Glucose 79.6 mg/dL, Glucose (serum) 81.5 mg/dL, HbA1c 6.0 %, Total Cholesterol 162.1 mg/dL, HDL Cholesterol 38.4 mg/dL, Triglycerides 115.5 mg/dL, Creatinine 3.5 mg/dL
Active conditions: Essential Hypertension, Prediabetes
Medications: Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.0% (prediabetes range 5.7-6.4%)
- BMI 30.3 (obese)
- Age 61 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 36yo Male
Vitals: BP 132/86 mmHg, BMI 30.0, Weight 98.8 kg, HR 95 bpm
Labs: Glucose 71.4 mg/dL, HbA1c 6.1 %, Total Cholesterol 160.2 mg/dL, HDL Cholesterol 55.7 mg/dL, Triglycerides 117.8 mg/dL, Creatinine 1.5 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.1% (prediabetes range 5.7-6.4%)
- BMI 30.0 (obese)
- History of prediabetes

**Hypertension: MODERATE**
- BP 132/86 mmHg (elevated)
- BMI 30.0 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 62yo Female
Vitals: BP 125/95 mmHg, BMI 20.6, Weight 58.9 kg, HR 96 bpm
Labs: Glucose 67.5 mg/dL, HbA1c 6.4 %, Total Cholesterol 129.2 mg/dL, HDL Cholesterol 56.1 mg/dL, Triglycerides 133.3 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.4% (prediabetes range 5.7-6.4%)
- Age 62 years (≥45 increases risk)
- History of prediabetes

**Hypertension: HIGH**
- BP 125/95 mmHg (Stage 1+ hypertension)
- Age 62 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Confirm elevated BP on 2 separate occasions
4. Consider initiating antihypertensive therapy
5. Order baseline labs: renal function, electrolytes, lipid panel
6. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 63yo Male
Vitals: BP 124/92 mmHg, BMI 27.6, Weight 88.6 kg, HR 87 bpm
Labs: Glucose 85.2 mg/dL, Glucose (serum) 85.2 mg/dL, HbA1c 3.0 %, Total Cholesterol 281.8 mg/dL, HDL Cholesterol 58.3 mg/dL, Triglycerides 146.2 mg/dL, Creatinine 2.5 mg/dL
Active conditions: Essential Hypertension, Prediabetes, Diabetic Kidney Disease
Medications: Simvastatin 20 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 27.6 (overweight)
- Age 63 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 22yo Female
Vitals: BP 122/79 mmHg, BMI 24.5, Weight 63.8 kg, HR 67 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 122/79 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 39yo Female
Vitals: BP 96/83 mmHg, BMI 29.9, Weight 72.5 kg, HR 88 bpm
Labs: Total Cholesterol 145.7 mg/dL, HDL Cholesterol 46.9 mg/dL, Triglycerides 141.2 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 29.9 (overweight)

**Hypertension: MODERATE**
- BP 96/83 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 50yo Female
Vitals: BP 110/75 mmHg, BMI 36.8, Weight 94.9 kg, HR 66 bpm
Labs: Glucose 81.1 mg/dL, Glucose (serum) 89.1 mg/dL, HbA1c 6.3 %, Total Cholesterol 133.9 mg/dL, HDL Cholesterol 59.9 mg/dL, Triglycerides 103.1 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 36.8 (obese)
- Age 50 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BMI 36.8 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 6yo Male
Vitals: BP 130/71 mmHg, BMI 16.1, Weight 21.1 kg, HR 63 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 130/71 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 96yo Female
Vitals: BP 133/98 mmHg, BMI 30.0, Weight 95.5 kg, HR 81 bpm
Labs: Glucose 72.0 mg/dL, HbA1c 6.0 %, Total Cholesterol 190.1 mg/dL, HDL Cholesterol 60.0 mg/dL, Triglycerides 109.9 mg/dL, Creatinine 2.7 mg/dL
Active conditions: Prediabetes, Essential Hypertension, Type 2 Diabetes
Medications: Simvastatin 20 MG Oral Tablet, 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, lisinopril 10 MG Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 0yo Female
Vitals: BP 110/68 mmHg, Weight 3.9 kg, HR 94 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 72yo Female
Vitals: BP 114/73 mmHg, BMI 28.2, Weight 83.7 kg, HR 61 bpm
Labs: Glucose 64.7 mg/dL, Glucose (serum) 73.1 mg/dL, HbA1c 3.1 %, Total Cholesterol 174.0 mg/dL, HDL Cholesterol 77.2 mg/dL, Triglycerides 121.7 mg/dL, Creatinine 2.8 mg/dL
Active conditions: Essential Hypertension, Prediabetes, Diabetic Kidney Disease
Medications: Simvastatin 20 MG Oral Tablet, Simvastatin 10 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 28.2 (overweight)
- Age 72 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 12yo Male
Vitals: BP 106/79 mmHg, BMI 24.0, Weight 52.7 kg, HR 67 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 63yo Female
Vitals: BP 103/56 mmHg, BMI 30.2, Weight 90.8 kg, HR 61 bpm
Labs: Glucose 92.8 mg/dL, Glucose (serum) 97.7 mg/dL, HbA1c 5.3 %, Total Cholesterol 194.0 mg/dL, HDL Cholesterol 79.2 mg/dL, Triglycerides 118.9 mg/dL, Creatinine 2.8 mg/dL
Medications: Simvastatin 20 MG Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.2 (obese)
- Age 63 years (≥45 increases risk)

**Hypertension: MODERATE**
- BMI 30.2 (obesity increases BP risk)
- Age 63 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 85yo Female
Vitals: BP 139/96 mmHg, BMI 27.5, Weight 70.7 kg, HR 85 bpm
Labs: Glucose 94.9 mg/dL, Glucose (serum) 94.9 mg/dL, HbA1c 3.3 %, Total Cholesterol 292.5 mg/dL, HDL Cholesterol 55.1 mg/dL, Triglycerides 182.3 mg/dL, Creatinine 0.5 mg/dL
Active conditions: Prediabetes, Diabetic Kidney Disease
Medications: hydrochlorothiazide 12.5 MG / lisinopril 20 MG Oral Tablet, Simvastatin 20 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin]

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 27.5 (overweight)
- Age 85 years (≥45 increases risk)
- History of prediabetes

**Hypertension: HIGH**
- BP 139/96 mmHg (Stage 1+ hypertension)
- Age 85 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Confirm elevated BP on 2 separate occasions
4. Consider initiating antihypertensive therapy
5. Order baseline labs: renal function, electrolytes, lipid panel
6. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 57yo Male
Vitals: BP 92/62 mmHg, BMI 30.4, Weight 82.0 kg, HR 92 bpm
Labs: Glucose 90.3 mg/dL, Glucose (serum) 94.0 mg/dL, HbA1c 6.1 %, Total Cholesterol 267.8 mg/dL, HDL Cholesterol 63.0 mg/dL, Triglycerides 144.7 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Prediabetes, Type 2 Diabetes, Diabetic Neuropathy
Medications: Simvastatin 20 MG Oral Tablet, 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: MODERATE**
- BMI 30.4 (obesity increases BP risk)
- Age 57 years (≥55 increases risk)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 41yo Male
Vitals: BP 144/89 mmHg, BMI 27.8, Weight 89.3 kg, HR 92 bpm
Labs: Total Cholesterol 149.8 mg/dL, HDL Cholesterol 31.1 mg/dL, Triglycerides 101.1 mg/dL
Active conditions: Essential Hypertension
Medications: lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.8 (overweight)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 8yo Male
Vitals: BP 115/83 mmHg, BMI 14.3, Weight 20.8 kg, HR 98 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 115/83 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 57yo Female
Vitals: BP 134/98 mmHg, BMI 28.1, Weight 76.5 kg, HR 90 bpm
Labs: Glucose 74.6 mg/dL, HbA1c 6.1 %, Total Cholesterol 113.9 mg/dL, HDL Cholesterol 50.1 mg/dL, Triglycerides 109.3 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.1% (prediabetes range 5.7-6.4%)
- BMI 28.1 (overweight)
- Age 57 years (≥45 increases risk)
- History of prediabetes

**Hypertension: HIGH**
- BP 134/98 mmHg (Stage 1+ hypertension)
- Age 57 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Confirm elevated BP on 2 separate occasions
4. Consider initiating antihypertensive therapy
5. Order baseline labs: renal function, electrolytes, lipid panel
6. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 59yo Female
Vitals: BP 134/64 mmHg, BMI 27.5, Weight 56.3 kg, HR 66 bpm
Labs: Glucose 96.3 mg/dL, HbA1c 6.2 %, Total Cholesterol 150.7 mg/dL, HDL Cholesterol 69.7 mg/dL, Triglycerides 144.3 mg/dL, Creatinine 3.0 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.2% (prediabetes range 5.7-6.4%)
- BMI 27.5 (overweight)
- Age 59 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BP 134/64 mmHg (elevated)
- Age 59 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 50yo Male
Vitals: BP 110/83 mmHg, BMI 30.1, Weight 86.8 kg, HR 89 bpm
Labs: Glucose 98.0 mg/dL, Total Cholesterol 205.8 mg/dL, HDL Cholesterol 61.6 mg/dL, Triglycerides 111.3 mg/dL, Creatinine 3.4 mg/dL
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.1 (obese)
- Age 50 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 110/83 mmHg (elevated)
- BMI 30.1 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 50yo Male
Vitals: BP 108/91 mmHg, BMI 23.7, Weight 76.9 kg, HR 79 bpm
Labs: Total Cholesterol 163.4 mg/dL, HDL Cholesterol 34.9 mg/dL, Triglycerides 107.0 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- Age 50 years (≥45 increases risk)

**Hypertension: HIGH**
- BP 108/91 mmHg (Stage 1+ hypertension)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 40yo Male
Vitals: BP 122/79 mmHg, BMI 30.2, Weight 91.7 kg, HR 84 bpm
Labs: Total Cholesterol 161.0 mg/dL, HDL Cholesterol 61.3 mg/dL, Triglycerides 138.7 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.2 (obese)

**Hypertension: MODERATE**
- BP 122/79 mmHg (slightly elevated)
- BMI 30.2 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 66yo Male
Vitals: BP 109/75 mmHg, BMI 27.7, Weight 96.1 kg, HR 100 bpm
Labs: Glucose 82.4 mg/dL, HbA1c 5.8 %, Total Cholesterol 280.8 mg/dL, HDL Cholesterol 67.3 mg/dL, Triglycerides 125.5 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.8% (prediabetes range 5.7-6.4%)
- BMI 27.7 (overweight)
- Age 66 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 66 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 16yo Male
Vitals: BP 112/77 mmHg, BMI 29.0, Weight 78.8 kg, HR 99 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 29.0 (overweight)

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 57yo Male
Vitals: BP 106/77 mmHg, BMI 30.1, Weight 88.9 kg, HR 94 bpm
Labs: Glucose 83.5 mg/dL, Glucose (serum) 83.5 mg/dL, HbA1c 3.3 %, Total Cholesterol 202.0 mg/dL, HDL Cholesterol 53.6 mg/dL, Triglycerides 117.6 mg/dL, Creatinine 4.2 mg/dL
Active conditions: Essential Hypertension, Prediabetes, Diabetic Kidney Disease
Medications: insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.1 (obese)
- Age 57 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 98yo Female
Vitals: BP 97/67 mmHg, BMI 27.5, Weight 76.7 kg, HR 94 bpm
Labs: Glucose 81.5 mg/dL, Glucose (serum) 81.9 mg/dL, HbA1c 5.6 %, Total Cholesterol 174.2 mg/dL, HDL Cholesterol 59.6 mg/dL, Triglycerides 118.3 mg/dL, Creatinine 3.3 mg/dL
Medications: Simvastatin 20 MG Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.5 (overweight)
- Age 98 years (≥45 increases risk)

**Hypertension: LOW**
- Age 98 years (≥55 increases risk)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 38yo Male
Vitals: BP 116/76 mmHg, BMI 30.0, Weight 91.2 kg, HR 90 bpm
Labs: Total Cholesterol 312.0 mg/dL, HDL Cholesterol 48.4 mg/dL, Triglycerides 142.0 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.0 (obese)

**Hypertension: MODERATE**
- BMI 30.0 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 68yo Female
Vitals: BP 117/80 mmHg, BMI 30.6, Weight 81.1 kg, HR 68 bpm
Labs: Glucose 73.0 mg/dL, HbA1c 6.2 %, Total Cholesterol 125.1 mg/dL, HDL Cholesterol 58.8 mg/dL, Triglycerides 112.4 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.2% (prediabetes range 5.7-6.4%)
- BMI 30.6 (obese)
- Age 68 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BP 117/80 mmHg (elevated)
- BMI 30.6 (obesity increases BP risk)
- Age 68 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 48yo Female
Vitals: BP 119/85 mmHg, BMI 27.7, Weight 73.4 kg, HR 61 bpm
Labs: Glucose 81.7 mg/dL, Glucose (serum) 81.7 mg/dL, HbA1c 3.2 %, Total Cholesterol 141.2 mg/dL, HDL Cholesterol 61.3 mg/dL, Triglycerides 131.7 mg/dL, Creatinine 2.8 mg/dL
Active conditions: Prediabetes, Essential Hypertension, Diabetic Kidney Disease
Medications: insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 27.7 (overweight)
- Age 48 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 8yo Female
Vitals: BP 130/77 mmHg, BMI 14.6, Weight 19.6 kg, HR 73 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 130/77 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 78yo Male
Vitals: BP 129/92 mmHg, BMI 30.2, Weight 92.8 kg, HR 81 bpm
Labs: Glucose 89.6 mg/dL, HbA1c 6.3 %, Total Cholesterol 179.1 mg/dL, HDL Cholesterol 59.5 mg/dL, Triglycerides 146.7 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 30.2 (obese)
- Age 78 years (≥45 increases risk)
- History of prediabetes

**Hypertension: HIGH**
- BP 129/92 mmHg (Stage 1+ hypertension)
- BMI 30.2 (obesity increases BP risk)
- Age 78 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Confirm elevated BP on 2 separate occasions
4. Consider initiating antihypertensive therapy
5. Order baseline labs: renal function, electrolytes, lipid panel
6. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 10yo Male
Vitals: BP 114/83 mmHg, BMI 15.6, Weight 32.8 kg, HR 87 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 114/83 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 76yo Male
Vitals: BP 96/83 mmHg, BMI 27.4, Weight 82.0 kg, HR 86 bpm
Labs: Glucose 92.9 mg/dL, HbA1c 5.4 %, Total Cholesterol 175.6 mg/dL, HDL Cholesterol 51.8 mg/dL, Triglycerides 120.8 mg/dL, Creatinine 0.7 mg/dL
Active conditions: Prediabetes, Essential Hypertension, Type 2 Diabetes, Diabetic Neuropathy
Medications: Simvastatin 20 MG Oral Tablet, 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)